Symbol not found

:BNKL  
0.00
0.00 (0.00%)
Earnings Announcements

BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results

Published: 11/10/2021 12:45 GMT
(BNKL) - Bionik Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results.
Q2 Revenue $200,000.
Q2 Loss per Share $0.21 Excluding Items.
Q2 Loss per Share $0.22.